Austria: AOP Health Group chooses co-CEO management structure

B Nachbaur and M Steinhart fotocredit_Schedl

AOP Orphan Pharmaceutical (AOP Health), an Austrian pharmaceutical company specializing in R&D of therapies for rare diseases and intensive care medicine, has restructured its top management positions at its Vienna headquarters. As of January 19, 2023, Martin Steinhart and Bernhard Nachbaur succeeded Georg Fischer as co-CEOs. The pandemic and associated supply bottlenecks, supply chain issues,…

You must be a HMI Subscriber to view this content.

Subscribe Now »